This HTML5 document contains 84 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80681924
rdf:type
wikibase:Item
schema:description
2008 թվականի փետրվարի 11-ին հրատարակված գիտական հոդված wetenschappelijk artikel наукова стаття, опублікована в лютому 2008 scientific article published on 11 February 2008 artículu científicu espublizáu en febreru de 2008
p:P577
wds:Q80681924-2505EF64-392C-4EF4-98FB-26F69C4F9CCB
wdt:P577
2008-02-11T00:00:00Z
p:P2093
wds:Q80681924-0279F4AD-3162-47CD-A525-1D49C8FA6D70 wds:Q80681924-2F40228A-BF21-4274-9D5C-517DEEBB32EA wds:Q80681924-24927572-B5DF-4D62-A84A-3C27FF58BEF1 wds:Q80681924-466F5386-3D41-4453-8734-4A0CDDFAFB40 wds:Q80681924-5B6B5FF5-19B9-40D7-8642-554DA909AD2C wds:Q80681924-5250C3F9-5CA7-4976-B8D9-8D0DEB558FC6 wds:Q80681924-5A9CF534-ECAC-4AC9-B998-54E143D54098 wds:Q80681924-B65325FA-7205-4DF5-97E4-58D71E434234 wds:Q80681924-B1433124-8DC7-48A1-AD11-9C5A2E4A94F0 wds:Q80681924-DF65E9A0-1894-4F79-A798-8FBE2E933CE9 wds:Q80681924-CD59E955-15DA-4586-886C-1D4A5D852B10 wds:Q80681924-FEF876F5-9759-417B-A04C-225A6B2B3A82 wds:Q80681924-FAADD08B-8F57-407B-82BE-EA19D09F6E2E
wdt:P2093
David J Maron Marcin Dada Sean W Hayes Robert A O'Rourke COURAGE Investigators Pamela M Hartigan Gary V Heller Benjamin McCallister G B John Mancini Ronald G Schwartz John Friedman Peter Berger Eric R Bates
rdfs:label
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy
skos:prefLabel
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy
schema:name
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy
p:P50
wds:Q80681924-C7618206-309B-47A3-AD19-2670A0488921 wds:Q80681924-D38BBD99-E07A-4FA7-8092-CBF7C877AE3D wds:Q80681924-FF327ECF-DB64-44F5-8815-A15FF8CF135C wds:Q80681924-4359A3D5-7D5A-438D-A113-580C19F0AB62 wds:Q80681924-4572B171-F6E5-4A6D-9FB0-EACE2381A17A wds:Q80681924-06C8260F-F5D1-4356-829C-FFFDBB27B10B wds:Q80681924-1BEA3CD2-65DF-4705-BF51-9465C9071B24 wds:Q80681924-9F83706E-C826-40AC-BCF5-C02215F0EDFA wds:Q80681924-A61B8C22-4970-4F64-903F-E5A89EC66709 wds:Q80681924-A8625D8B-7522-4C16-AB41-2FF61480FCE8 wds:Q80681924-ADF26F4C-33C1-4480-B3E2-D5EB7E39A0B0 wds:Q80681924-71414931-5BAD-4CCB-A1D4-72E54360D1B8 wds:Q80681924-864F73E7-B51A-41F1-AD22-9FAB37152530
wdt:P50
wd:Q114407037 wd:Q114407007 wd:Q114268000 wd:Q89697826 wd:Q94570815 wd:Q98158272 wd:Q60611748 wd:Q114407038 wd:Q60503412 wd:Q56517381 wd:Q59976170 wd:Q89794201 wd:Q114407034
p:P1476
wds:Q80681924-2C2C3411-729C-4AF1-8975-AFA11EB13757
wdt:P1476
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy
p:P304
wds:Q80681924-B354F955-CB89-4F7F-9373-3824E77C0BFC
wdt:P304
1283-1291
p:P31
wds:Q80681924-66F9B318-6C05-4ACA-B6C9-3CBE86F25218
wdt:P31
wd:Q13442814
p:P698
wds:Q80681924-74671F22-C4FD-424F-9DFB-18CD6F97CAFF
wdtn:P698
n11:18268144
wdt:P698
18268144
p:P1433
wds:Q80681924-7D58AF82-2985-427C-9C9F-98C00C153E9A
wdt:P1433
wd:Q578091
p:P433
wds:Q80681924-468D91AC-1121-4410-BAFF-BAF9DE6554A0
p:P478
wds:Q80681924-B2A4C960-7D76-46BB-9466-C5A7CF90DDE4
wdt:P433
10
wdt:P478
117
p:P356
wds:Q80681924-E9C8DC55-2403-4A80-B47E-A968337BE7D7
wdtn:P356
n12:CIRCULATIONAHA.107.743963
wdt:P356
10.1161/CIRCULATIONAHA.107.743963